49 2023 sicily English-speaking jobs in Lazio

The company’s consolidated revenues for fiscal year 2023 (ended March 31, 2024) totalled 8,564.3 billion

At the end of 2023 we finished construction of our first solar park and windfarm, which are now exporting

Qualification LS | 2nd cycle university degree Weekly Hours 40 Posted: 22 August 2023 As a leading Cybersecurity

sale Work location : Lazio (RM, RI, VT, FR, LT) Contract : Fixed-term employment contract from June 2023

Ice Cream business, you will work for the Global, leading Ice Cream player with €7.9bn Turn Over in 2023

Ice Cream business, you will work for the Global, leading Ice Cream player with €7.9bn Turn Over in 2023

Ice Cream business, you will work for the Global, leading Ice Cream player with €7.9bn Turn Over in 2023

Ice Cream business, you will work for the Global, leading Ice Cream player with €7.9bn Turn Over in 2023

Cream business or considering working for it, you will join a global leader with a €7.9bn turnover in 2023

In 2023, the Group generated revenues of €5.8 billion. ... With approximately 1,200 employees and a 2023 revenue of €97.8 million, Sopra Steria operates in the

In full expansion (€490 million in turnover in 2019, €670 million in 2023, representing growth of 35%

In 2023, the Group generated €5.8 billion in revenue.

administration bodies in areas such as: Public works, service, and supply contracts (Legislative decree no. 36/2023

Consolidated Financial Results at June 30, 2023 For our project start-up team based in Rome and focused

As a rapidly growing company (€490M in revenue in 2019, €670M in 2023—a 35% increase—with a target of

As a rapidly growing company (€490M in revenue in 2019, €670M in 2023—a 35% increase—with a target of

Awards Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

and as the World's Best Independent Hotel PMS Provider 2022 and 2023 by the World Travel Tech Awards ... achievements don't stop there; Mews was also listed among the World's Best Hotel PMS Provider 2023

Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023

Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023